respiratory system
• by 12 months of age, mice develop lymphocytic interstitial pneumonitis
• however, no evidence of arthritis or systemic vasculitis are seen
|
digestive/alimentary system
• by 6 months of age, mice show a decline in salivary gland secretion which becomes progressively worse over time
|
• 39 of 40 mice develop lymphocytic infiltration of salivary glands that is age dependent
(J:117018)
• lymphocytic infiltration of the salivary glands is comprised of predominately B220+ B cells with scattered CD4+ T and only rare CD8+ T cells and CD138+ plasma cells are seen in clusters, mostly in a perivascular distribution
(J:145185)
|
• mice show early inflammation in parotid glands at 15 months of age and malignant changes at 18 months
• however, the sublingual glands are normal
|
• mice develop lymphocytic infiltration into submandibular glands at 9 months and malignant change is seen by 18 months of age
|
vision/eye
• mice show lymphocytic infiltration in the lacrimal glands by 12 months of age
|
endocrine/exocrine glands
• by 6 months of age, mice show a decline in salivary gland secretion which becomes progressively worse over time
|
• 39 of 40 mice develop lymphocytic infiltration of salivary glands that is age dependent
(J:117018)
• lymphocytic infiltration of the salivary glands is comprised of predominately B220+ B cells with scattered CD4+ T and only rare CD8+ T cells and CD138+ plasma cells are seen in clusters, mostly in a perivascular distribution
(J:145185)
|
• mice show early inflammation in parotid glands at 15 months of age and malignant changes at 18 months
• however, the sublingual glands are normal
|
• mice develop lymphocytic infiltration into submandibular glands at 9 months and malignant change is seen by 18 months of age
|
• mice show lymphocytic infiltration in the lacrimal glands by 12 months of age
|
hematopoietic system
• aged mice develop mild splenomegaly
|
• mice exhibit an increase in CD19+, CD38+ sIgD-low germinal center B cells in the spleen
|
• mice show an increase in the percentage of CD5+CD19+IgM+sIgD-low B1 cells in the peritoneum
|
• mice exhibit an increase in CD19+ splenic B2 cells
|
• mice exhibit an increase in CD19+, CD21+, IgM+ marginal zone B cells
|
• mice show an increase in CD19-CD138+ plasma cells
|
• mice exhibit increased IgG anti-NP vaccine responses to the T-dependent antigen NP-OVA
• mice exhibit increased IgM anti-NP vaccine responses to the T-independent antigen NP-Ficoll
|
• mice develop hypergammaglobulinemia by 6 months of age involving both IgG and IgM
|
• mice show an increase in IgA at 9 months of age
|
• mice show a more prominent elevation in IgG2a, but not other IgG subclasses
|
• all mice exhibit increased levels of IgM anti-cardiolipin autoantibody in sera
|
homeostasis/metabolism
• by 6 months of age, mice show a decline in salivary gland secretion which becomes progressively worse over time
|
• mice show an increase in IFN-alpha in the sera of 10-12 months of age, however levels of IFN-beta and IFN-gamma are similar to controls
|
• mice have mild proteinuria by 8 months of age but never develop renal dysfunction
|
immune system
• 39 of 40 mice develop lymphocytic infiltration of salivary glands that is age dependent
(J:117018)
• lymphocytic infiltration of the salivary glands is comprised of predominately B220+ B cells with scattered CD4+ T and only rare CD8+ T cells and CD138+ plasma cells are seen in clusters, mostly in a perivascular distribution
(J:145185)
|
• mice show early inflammation in parotid glands at 15 months of age and malignant changes at 18 months
• however, the sublingual glands are normal
|
• mice develop lymphocytic infiltration into submandibular glands at 9 months and malignant change is seen by 18 months of age
|
• mice show lymphocytic infiltration in the lacrimal glands by 12 months of age
|
• aged mice develop mild splenomegaly
|
• mice exhibit an increase in CD19+, CD38+ sIgD-low germinal center B cells in the spleen
|
• mice show an increase in the percentage of CD5+CD19+IgM+sIgD-low B1 cells in the peritoneum
|
• mice exhibit an increase in CD19+ splenic B2 cells
|
• mice exhibit an increase in CD19+, CD21+, IgM+ marginal zone B cells
|
• mice show an increase in CD19-CD138+ plasma cells
|
• mice exhibit increased IgG anti-NP vaccine responses to the T-dependent antigen NP-OVA
• mice exhibit increased IgM anti-NP vaccine responses to the T-independent antigen NP-Ficoll
|
• mice develop hypergammaglobulinemia by 6 months of age involving both IgG and IgM
|
• mice show an increase in IgA at 9 months of age
|
• mice show a more prominent elevation in IgG2a, but not other IgG subclasses
|
• all mice exhibit increased levels of IgM anti-cardiolipin autoantibody in sera
|
• mice show an increase in IFN-alpha in the sera of 10-12 months of age, however levels of IFN-beta and IFN-gamma are similar to controls
|
• aged mice develop mild lymphoid hyperplasia
|
• 9 month old mice exhibit IgM deposits in peri-acinar cells of submandibular glands and by 15 months of age, IgM deposits are further seen in the cytosol of acinar cells
|
• 9-17 month old mice develop autoantibodies and sialadenitis indicative of Sjogren's syndrome
(J:117018)
|
• all mice exhibit increased levels of IgM anti-cardiolipin autoantibody in sera
• some mice show increased levels of one or more autoantibodies, including IgG ANA, anti-dsDNA, anti-chromatin, anti-Ro, anti-La, anti-Sm, and anti-nRNP, however many mice do not exhibit increased levels of these
• females tend to develop autoimmunity earlier and more severely than males
|
• deposition of IgM in the glomeruli and weak deposition of IgG and complement, indicating immune complex-mediated nephritis
|
• by 12 months of age, mice develop lymphocytic interstitial pneumonitis
• however, no evidence of arthritis or systemic vasculitis are seen
|
neoplasm
• 96% of 12-20 month old mice develop lymphoma, with a few mice showing lymphoma restricted to the spleen but most showing it in the liver and gastrointestinal tract or lung
• lymphoma has features of large B cell lymphoma, express CD5 and CD19 but not CD21 and variably CD23
• lymphoma contains Ig gene rearrangements suggesting a B cell tumor of monoclonal origin
|
renal/urinary system
• mice have mild proteinuria by 8 months of age but never develop renal dysfunction
|
• deposition of IgM in the glomeruli and weak deposition of IgG and complement, indicating immune complex-mediated nephritis
|
• deposition of IgM in the glomeruli and weak deposition of IgG and complement
|
• mild increase in mesangial cells in the kidneys at 10 months of age
|
cardiovascular system
• deposition of IgM in blood vessels
|
cellular
• mild increase in mesangial cells in the kidneys at 10 months of age
|
growth/size/body
• aged mice develop mild splenomegaly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Sjogren's syndrome | DOID:12894 |
OMIM:270150 |
J:145185 |